{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:57:46Z","timestamp":1788904666763,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG-GRG2025\\u201300274-ICMS"],"award-info":[{"award-number":["MYRG-GRG2025\\u201300274-ICMS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0002\/2025\/NRP"],"award-info":[{"award-number":["0002\/2025\/NRP"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0086\/2021\/A2"],"award-info":[{"award-number":["0086\/2021\/A2"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010096","name":"South China Medical University","doi-asserted-by":"publisher","award":["2023B1212120005"],"award-info":[{"award-number":["2023B1212120005"]}],"id":[{"id":"10.13039\/501100010096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015249","name":"University of Macau Institute of Chinese Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.colsurfb.2026.115848","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:10:06Z","timestamp":1779721806000},"page":"115848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tetrandrine nanocrystals development for enhanced transdermal delivery and anti-psoriatic activity on imiquimod-induced psoriasis mouse model"],"prefix":"10.1016","volume":"266","author":[{"given":"Yulu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.colsurfb.2026.115848_bib1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.colsurfb.2026.115848_bib2","article-title":"GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets","author":"Dand","year":"2023","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115848_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115848_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13020-021-00550-y","article-title":"A review of Chinese medicine for the treatment of psoriasis: principles, methods and analysis","volume":"16","author":"Su","year":"2021","journal-title":"Chin. Med"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115848_bib5","doi-asserted-by":"crossref","first-page":"17089","DOI":"10.1007\/s00210-025-04317-2","article-title":"Suppressive effect of topical moxifloxacin on imiquimod-induced model of psoriasis in mice","volume":"398","author":"Abbas","year":"2025","journal-title":"Naunyn-Schmiede 's. Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115848_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s10735-025-10416-4","article-title":"Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice","volume":"56","author":"Ali","year":"2025","journal-title":"J. Mol. Histol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115848_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40259-022-00569-z","article-title":"Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities","volume":"37","author":"Jiang","year":"2023","journal-title":"BioDrugs"},{"issue":"40","key":"10.1016\/j.colsurfb.2026.115848_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba6584","article-title":"Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4(+)Foxp3(+) regulatory T cells","volume":"6","author":"He","year":"2020","journal-title":"Sci. Adv."},{"issue":"17","key":"10.1016\/j.colsurfb.2026.115848_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173880","article-title":"The Defect in Regulatory T Cells in Psoriasis and Therapeutic Approaches","volume":"10","author":"Kanda","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.colsurfb.2026.115848_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine--A molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.colsurfb.2026.115848_bib11","article-title":"Topical Application of Tetrandrine Nanoemulsion Promotes the Expansion of CD4(+)Foxp3(+) Regulatory T Cells and Alleviates Imiquimod-Induced Psoriasis in Mice","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.colsurfb.2026.115848_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/IJN.S494224","article-title":"Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration","volume":"20","author":"Yanamadala","year":"2025","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115848_bib13","doi-asserted-by":"crossref","first-page":"13165","DOI":"10.2147\/IJN.S531873","article-title":"Self-Assembled Carrier Free Oligomeric Proanthocyanidin\/Tetrandrine Nanoparticles Ameliorate Osteoarthritis via Anti-Inflammatory and Anti-Ferroptotic Pathways","volume":"20","author":"Xing","year":"2025","journal-title":"Int J. Nanomed."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115848_bib14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10717544.2022.2058648","article-title":"Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: in vitro and in vivo assessment","volume":"29","author":"Radwan","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2026.115848_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/IJN.S431599","article-title":"Preparation, Characterization, and Anti-Lung Cancer Activity of Tetrandrine-Loaded Stealth Liposomes","volume":"19","author":"Fang","year":"2024","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.colsurfb.2026.115848_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.644952","article-title":"Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis","volume":"12","author":"Xie","year":"2021","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115848_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12247-020-09499-1","article-title":"Nanocrystals: Characterization Overview, Applications in Drug Delivery, and Their Toxicity Concerns","volume":"17","author":"Jahangir","year":"2020","journal-title":"J. Pharm. Innov."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115848_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/17425247.2018.1444025","article-title":"Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery","volume":"15","author":"Patel","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115848_bib19","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.drudis.2021.07.010","article-title":"Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery","volume":"26","author":"Parmar","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.colsurfb.2026.115848_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113231","article-title":"Nanocrystals as an emerging nanocarrier for the management of dermatological diseases","volume":"225","author":"Parveen","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115848_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16121561","article-title":"Nanocrystals in dermal drug delivery: a breakthrough for enhanced skin penetration and targeted skin disorder treatments","volume":"16","author":"Alnaim","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115848_bib22","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1080\/10717544.2019.1682721","article-title":"Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery","volume":"26","author":"Liu","year":"2019","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115848_bib23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.drudis.2018.01.016","article-title":"Pharmaceutical nanocrystals: production by wet milling and applications","volume":"23","author":"Malamatari","year":"2018","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115848_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.04.082","article-title":"Reducing systemic absorption and macrophages clearance of genistein by lipid-coated nanocrystals for pulmonary delivery","volume":"34","author":"He","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.colsurfb.2026.115848_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.carbpol.2018.08.112","article-title":"Hyaluronic acid based nanocrystals hydrogels for enhanced topical delivery of drug: a case study","volume":"202","author":"Wei","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2026.115848_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2017.03.385","article-title":"Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel","volume":"254","author":"Sun","year":"2017","journal-title":"J. Control Release"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115848_bib27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.apsb.2020.11.008","article-title":"Uptake and trafficking of different sized PLGA nanoparticles by dendritic cells in imiquimod-induced psoriasis-like mice model","volume":"11","author":"Lin","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"2S","key":"10.1016\/j.colsurfb.2026.115848_bib28","article-title":"Mitigative effects of a topically-applied combination of cimifugin and vinpocetine on a murine psoriasis-like model","volume":"37","author":"Abbas","year":"2025","journal-title":"Pharmakeftiki"},{"key":"10.1016\/j.colsurfb.2026.115848_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2016.10.004","article-title":"Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis","volume":"243","author":"Jain","year":"2016","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115848_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7150\/thno.22711","article-title":"Recent Advances in the Application of Vitamin E TPGS for Drug Delivery","volume":"8","author":"Yang","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115848_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10717544.2020.1856224","article-title":"Progress in the development of stabilization strategies for nanocrystal preparations","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.colsurfb.2026.115848_bib32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2147\/IJN.S433686","article-title":"Gel-Dispersed Nanostructured Lipid Carriers Loading Thymol Designed for Dermal Pathologies","volume":"19","author":"Folle","year":"2024","journal-title":"Int J. Nanomed."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115848_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cosmetics8030069","article-title":"Towards Optimal pH of the Skin and Topical Formulations: From the Current State of the Art to Tailored Products","volume":"8","author":"Luki\u0107","year":"2021","journal-title":"Cosmetics"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115848_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/gels9070587","article-title":"Microemulsion-Based Keratin-Chitosan Gel for Improvement of Skin Permeation\/Retention and Activity of Curcumin","volume":"9","author":"Niu","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.colsurfb.2026.115848_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119737","article-title":"Enhanced transdermal delivery of curcumin nanosuspensions: A mechanistic study based on co-localization of particle and drug signals","volume":"588","author":"Shi","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"10275","key":"10.1016\/j.colsurfb.2026.115848_bib36","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115848_bib37","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1007\/s00210-024-03017-7","article-title":"Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice","volume":"397","author":"Khafaji","year":"2024","journal-title":"Naunyn-Schmiede 's. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115848_bib38","first-page":"35","article-title":"Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis","volume":"19","author":"Salman","year":"2024","journal-title":"J. Taibah Univ. Med Sci."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115848_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-019-00742-7","article-title":"T cell pathology in skin inflammation","volume":"41","author":"Sabat","year":"2019","journal-title":"Semin Immunopathol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115848_bib40","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s00210-024-03406-y","article-title":"The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation","volume":"398","author":"Ridha-Salman","year":"2025","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115848_bib41","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.12991\/jrespharm.1734970","article-title":"Protective effect of cinnarizine on imiquimod-induced mouse model of psoriasis","volume":"29","author":"Farooq Ali","year":"2025","journal-title":"J. Res. Pharm."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526004364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526004364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:24:33Z","timestamp":1785785073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526004364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0927776526004364"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115848","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrandrine nanocrystals development for enhanced transdermal delivery and anti-psoriatic activity on imiquimod-induced psoriasis mouse model","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115848"}}